CB
Coherus BioSciences Inc
🇺🇸XNAS.CHRSUnited StatesHealthcare
$1.29USDdown -0.05 (-3.73%)OpenDelayed5:08 PM
Price$1.29-0.05 (-3.73%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US19249H1032
- CUSIP
- 19249H103
Company
- Employees
- 144
- Headquarters
- Redwood City, United States
- Website
- https://www.coherus.com
- CEO
- Mr. Dennis M. Lanfear
Market
- Shares outstanding
- 154.5M
- Market cap
- $199.31M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $207.03M
- EPS LTM
- -$0.85
- P/E LTM
- -1.69
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $50.94M-64.32%down year on year
- Net income
- -$130.96M+17.82%up year on year
- Gross margin
- 63.55%+13.33%up year on year
- Free cash flow
- -$243.92M-130.4%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.